Elena Morozova (E V Morozova)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 8

Top Topics

Tyrosine Kinase

Stem Cell Transplantation

Chronic Myeloid Leukemia

Top Venues

Bone marrow transplantation

This page only lists publications with an associated author ORCID identifier.

Publications

Christian Niederwieser, Simona Iacobelli, Georg-Nikolaus Franke, Linda Koster, Marleen van Os, Uwe Platzbecker, Kai Hübel, Christof Scheid, Lutz Peter Müller, Matthias Stelljes, Elena Morozova, Jakob R Passweg, Francesco Onida, Peter Dreger, Riccardo Saccardi, Marco Ladetto, Urpu Salmenniemi, Wolfgang Andreas Bethge, Xavier Poiré, Guido Kobbe, Donal P McLornan, Marie Robin, Nicolaus Kröger
Reduced intensity versus myeloablative conditioning for MDS: long-term results of an EBMT phase III study (RICMAC). Bone marrow transplantation 59 (8) (2024)
Christian Niederwieser, Simona Iacobelli, Georg-Nikolaus Franke, Linda Koster, Marleen van Os, Uwe Platzbecker, Kai Hübel, Christof Scheid, Lutz Peter Müller, Matthias Stelljes, Elena Morozova, Jakob R Passweg, Francesco Onida, Peter Dreger, Riccardo Saccardi, Marco Ladetto, Urpu Salmenniemi, Wolfgang Andreas Bethge, Xavier Poiré, Guido Kobbe, Donal P McLornan, Marie Robin, Nicolaus Kröger
Reduced intensity versus myeloablative conditioning for MDS: long-term results of an EBMT phase III study (RICMAC). Bone marrow transplantation 59 (8) (2024)
Christian Niederwieser, Simona Iacobelli, Georg-Nikolaus Franke, Linda Koster, Marleen van Os, Uwe Platzbecker, Kai Hübel, Christof Scheid, Lutz Peter Müller, Matthias Stelljes, Elena Morozova, Jakob R Passweg, Francesco Onida, Peter Dreger, Riccardo Saccardi, Marco Ladetto, Urpu Salmenniemi, Wolfgang Andreas Bethge, Xavier Poiré, Guido Kobbe, Donal P McLornan, Marie Robin, Nicolaus Kröger
Reduced intensity versus myeloablative conditioning for MDS: long-term results of an EBMT phase III study (RICMAC). Bone marrow transplantation (2024)
Christian Niederwieser, Simona Iacobelli, Georg-Nikolaus Franke, Linda Koster, Marleen van Os, Uwe Platzbecker, Kai Hübel, Christof Scheid, Lutz Peter Müller, Matthias Stelljes, Elena Morozova, Jakob R Passweg, Francesco Onida, Peter Dreger, Riccardo Saccardi, Marco Ladetto, Urpu Salmenniemi, Wolfgang Andreas Bethge, Xavier Poiré, Guido Kobbe, Donal P McLornan, Marie Robin, Nicolaus Kröger
Reduced intensity versus myeloablative conditioning for MDS: long-term results of an EBMT phase III study (RICMAC). Bone marrow transplantation 59 (8) (2024)
A G Gevorgian, Andrei Vadimovich Kozlov, P S Tolkunova, Ilya Viktorovich Kazantsev, T V Yukhta, Elena Morozova, Alexander Dmitrievich Kulagin, Y A Punanov, O G Zheludkova, L S Zubarovskaya
Tandem autologous hematopoietic stem cell transplantation for embryonal brain tumors in infants and very young children. Bone marrow transplantation 57 (4) (2022)
Ivan Sergeevich Moiseev, Maria Barabanshikova, Anna Dotsenko, Anna Smirnova, Yulia Vlasova, Elena Morozova, Sergey Bondarenko, Alexander Dmitrievich Kulagin
First-line steroid-free systemic treatment of acute and chronic graft-versus-host disease after novel prophylaxis regimens. Bone marrow transplantation (2022)
Christian Niederwieser, Elena Morozova, Ludmila Zubarovskaya, Tatjana Zabelina, Evgeny Klyuchnikov, Dietlinde Janson, Christine Wolschke, Maximilian Christopeit, Francis Ayuk, Ivan Sergeevich Moiseev, Boris V Afanasyev, Nicolaus M Kröger
Risk factors for outcome after allogeneic stem cell transplantation in patients with advanced phase CML. Bone marrow transplantation 56 (11) (2021)
Stavroula Masouridi-Levrat, Eduardo Olavarria, Simona Iacobelli, Mahmoud Aljurf, Elena Morozova, Riitta Niittyvuopio, Henrik Sengeloev, Peter Reményi, Grzegorz Helbig, Paul Browne, Arnold Ganser, Arnon Nagler, John A Snowden, Marie Robin, Jakob Passweg, Gwendolyn Van Gorkom, Hélène Labussière Wallet, Jennifer Hoek, Henric-Jan Blok, Theo De Witte, Nicolaus Kroeger, Patrick J Hayden, Yves Chalandon, Ibrahim Yakoub Agha
Outcomes and toxicity of allogeneic hematopoietic cell transplantation in chronic myeloid leukemia patients previously treated with second-generation tyrosine kinase inhibitors: a prospective non-interventional study from the Chronic Malignancy Working Party of the EBMT. Bone marrow transplantation (2021)